Welcome to our dedicated page for Stryker news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker stock.
Stryker Corporation (NYSE: SYK) is described as a global leader in medical technologies, with a focus on MedSurg, Neurotechnology and Orthopaedics. The news flow around Stryker reflects this broad footprint, covering topics from product launches and clinical technology updates to quarterly financial results, leadership changes and portfolio transactions.
Investors following SYK news will see regular announcements of earnings results, including detailed third quarter and other period operating updates furnished via press releases and Form 8-K filings. These communications typically discuss segment performance in MedSurg and Neurotechnology and Orthopaedics, along with commentary from management on sales trends and margins.
Stryker also issues news about product innovation in orthopaedics and trauma. Recent examples include the launch of the FDA-cleared Incompass Total Ankle System for patients with end-stage ankle arthritis and updates on trauma offerings such as the Pangea platform and T2 Alpha system, which are designed to support complex fracture management. These announcements often coincide with major medical society meetings and highlight design goals and clinical use cases.
Corporate and strategic developments appear frequently in Stryker’s news stream. The company has reported leadership changes, such as the appointment of a President and Chief Operating Officer and the promotion of a new Group President, Orthopaedics. It has also communicated portfolio moves, including references to the divestiture of its spinal implant business and news that VB Spine LLC acquired Stryker’s U.S. spine implant business and a spine implant manufacturing facility in Cestas, France.
In addition, Stryker announces investor events, such as upcoming earnings webcasts, participation in healthcare conferences and Investor Day presentations. For investors and healthcare professionals, the SYK news page provides a centralized view of these financial, strategic and product-related updates, offering context on how the company’s medical technologies and corporate decisions evolve over time.
Stryker (NYSE: SYK) has entered into a definitive agreement to acquire Vocera Communications (NYSE: VCRA) for $79.25 per share, totaling approximately $2.97 billion in equity value. The deal enhances Stryker's Medical division by integrating Vocera's innovative digital care coordination platform, which aims to alleviate caregiver burdens and improve patient outcomes. Both companies' boards have unanimously approved the transaction, expected to close in Q1 2022, with a neutral impact on Stryker's 2022 net earnings per share.
Stryker (NYSE:SYK) will host a conference call on January 27, 2022, at 4:30 p.m. ET to discuss its operating results for Q4 2021, with final results released at 4:05 p.m. the same day. Interested parties can register for the call through this link. The call will also be available via a webcast on Stryker's Investor Relations page. A replay will be accessible afterward at provided numbers with a passcode.
Stryker is a global leader in medical technology, focusing on improving healthcare outcomes through innovative products.
Stryker (NYSE:SYK) announced a quarterly dividend increase to $0.695 per share, payable on January 31, 2022, to shareholders of record as of December 31, 2021. This marks a 10.3% increase compared to the previous year and quarter. CEO Kevin Lobo emphasized the company's strong sales growth and solid financial results, aligning with their capital allocation strategy. Stryker is recognized as a leading medical technology firm, focused on improving healthcare through innovative products across Orthopaedics, Medical and Surgical, and Neurotechnology and Spine.
Moss & Gilmore LLP announced a settlement with the U.S. Department of Justice regarding a False Claims Act lawsuit. Defendants Jeffrey M. Gallups, M.D., and Milton Hall Surgical Associates will pay $3,068,434 to resolve allegations of ordering unnecessary medical tests and surgeries for kickbacks. Entellus Medical, acquired by Stryker Corporation (NYSE:SYK), will also pay $1,200,000 for its involvement. Dr. Gallups previously pleaded guilty to healthcare fraud, with sentencing set for February 11, 2022. Failure to pay may result in a $5,388,863 judgment against them.
Stryker reported third-quarter results for 2021, with net sales of $4.2 billion, representing an 11.3% increase from 2020 and a 16.0% increase from 2019. Although organic net sales rose 4.5% year-over-year, reported operating income margin fell by 260 bps to 25.4%. Reported EPS decreased by 30.1% to $1.14, while adjusted EPS rose 2.8% to $2.20. Key segments showed varied growth, with Orthopaedics increasing by 16.1% but experiencing a decline in organic sales. The company adjusted its 2021 outlook, forecasting organic sales growth of 7% to 8% from 2019.
Stryker (NYSE:SYK) will host an Analyst Meeting on November 18, 2021, at 2:30 p.m. ET, in Mahwah, New Jersey. A webcast of the event will be available on Stryker's website, where it will be archived for later viewing. To join via phone, call (844) 200-6205 (domestic) or (929) 526-1599 (international) with access code 695616. A recorded version will be accessible from 8:30 p.m. ET on November 18 until 11:59 p.m. ET on November 25, 2021. For further inquiries, contact their Investor Relations team.
Stryker (NYSE:SYK) will host a conference call on October 28, 2021, at 4:30 p.m. ET to discuss operating results for the quarter ending September 30, 2021. Preliminary results will be released at 4:05 p.m. that day. Participants can join by calling (833) 979-2711 (domestic) or (236) 714-2206 (international) with passcode 7351349. The call will be available via webcast on the company's website and archived after for later access until November 4, 2021.
Stryker is a leading medical technology company focused on enhancing healthcare.
THINK Surgical, Inc. has appointed Stuart F. Simpson as its new president and chief executive officer. With over 24 years at Stryker Corporation (NYSE: SYK), Simpson brings extensive experience in the orthopedic device sector, having previously led the Joint Replacement Division. He is confident about THINK's growth potential, particularly due to its innovative technology and open implant platform, which are believed to drive customer value and operational improvements. The company's robotic system has been used in numerous successful joint replacement surgeries worldwide.
Stryker (NYSE:SYK) will participate in Morgan Stanley’s 19th Annual Global Healthcare Conference on September 13, 2021. CEO Kevin Lobo will present virtually at 10:15 a.m. ET. The presentation will be available for live streaming and later replay on the Stryker website. Known for its innovative solutions in Orthopaedics, Medical and Surgical, and Neurotechnology, Stryker aims to enhance healthcare outcomes globally. For more information, visit www.stryker.com.
Stryker (NYSE:SYK) announced on August 18, 2021, that Timothy J. Scannell will retire as President and COO on March 31, 2023. He will serve as Advisor to the CEO from October 1, 2021, until retirement, ensuring a smooth transition of duties to Group Presidents J. Andrew Pierce and Spencer S. Stiles. Scannell has had a notable 31-year career at Stryker, contributing to its growth and success. The company remains focused on innovative medical technologies aimed at improving healthcare outcomes.